In an exclusive podcast interview with MassDevice.com, Rosa told us about the company's beginnings, his optimism for the still-sluggish heart failure treatment landscape and why it's so important that patients can disconnect from Sunshine Heart's flagship, outside-the-bloodstream C-Pulse heart assist device.
"In the U.S., for Class III heart failure there are about 1.5 million patients," Sunshine Heart CEO David Rosa told MassDevice.com in an exclusive podcast interview. "That's about 7 times the Class IV...
In his last interview as CEO of Philips Healthcare before taking the corner office at Quest Diagnostics, Steve Rusckowski tells MassDevice why 2011 was a tough year for the world's 7th-largest medical device maker, why things are looking up this year and how innovation can go hand-in-hand with lower costs.
It's not exactly news that the med-tech industry is under pressure from a variety of fronts – an uncertain regulatory environment, a looming tax burden and, not least, downward pricing pressure from its health care provider customers.
That last issue is particularly acute for medical device makers because their business model has long been anchored by developing high-ticket products and raising...
MassDevice discusses innovation, robotic surgery and Silicon Valley culture with Intuitive Surgical CEO Gary Guthart.
The threat that the fusion of humans and medical machines may leave patients vulnerable to the hackers and bugs of the digital world is beginning to resonate with device makers.
Karen Sandler was 31 years old, working at a non-profit organization providing free legal help to computer programmers, when she was diagnosed with an enlarged heart and informed that she'd need a machine to help keep her alive.
Her mother accompanied her the day a doctor recommended that Sandler undergo surgery to implant a medical device into her chest. He handed Sandler a pager-sized machine called a cardioverter defibrillator – a miniature,...
Accuray CEO Euan Thomson tells MassDevice about being a small fish in a big pond, managing growing pains and his strategies for breaking out in a well-established market.
After more than a year in the corner office of the newly pure-play medical device maker, Teleflex CEO Benson Smith tells MassDevice about dealing with the vagaries of Wall Street, what attracted a onetime history major to the medical device field, why Teleflex is poised to give the big kids on the block a run for their money and what the company looks for in potential acquisitions.